/Investor DB

StoryHouse — 2026 Investments

3 investments dated 2026 · listed companies and verified rows first · show all

Mantismantisbiotech.cominJan 2026

Mantis builds predictive models of individual physiology and behavior by aggregating consented personal data streams (wearables, device telemetry, clinical records) to forecast health outcomes and enable personalized medical decisions.

AI & Machine LearningData & InfrastructureDigital HealthEnterprise SoftwareHealthtechNew York City, US

Georgia Witchel(Founder/CEO)in

Co-investorsDecibel PartnersPioneerRitual CapitalSpot VCY CombinatorLiquid Ventures+2 more

TippingPoint Biosciencestippingpointbiosciences.cominMar 2026 · $4.5M

TippingPoint Biosciences is a therapeutics company developing a drug discovery platform that targets unstructured regions in chromatin proteins to treat diseases caused by dysfunctional genome chromatin packaging, with a focus on cancer.

BiotechDeep TechHealthtechSan Francisco, US

Laura Hsieh(Founder & CEO)in

Co-investorsFREEFLOWSOSVBrightEdgeEmpath VenturesSazzeXEIA Venture Partners

Ultraultra.techin𝕏Seed · Aug 2026

Ultra manufactures OP1, a stationary multi-purpose AI robot for warehouse automation that handles repetitive tasks like packing, sorting, and kitting.

Advanced ManufacturingAI & Machine LearningLogistics & Supply ChainRoboticsNew York City, US

Jon Miller Schwartz(CEO)inMax Friefeld(Founder)inChetan Parthiban(Founder)inJonathan Schwartz(Executive Officer, Director)inOliver Ortlieb(CTO)inEric Drymer(Founder)

Co-investorsAwz VenturesJude GomilaMaiora Rebel VenturesMK Venture CapitalMULTIMODAL VENTURESNextView Ventures+16 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.